Bio-Gene
BGT.AXBio-Gene Technology Limited Price (BGT.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
185,817,655
(10.7585)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Bio-Gene Technology LimitedCurrency: AUD
| YEAR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
76.00
+0% |
0.00
+0% |
186,415.00
+0% |
6,316.00
-97% |
344,450.00
+5,354% |
508,758.00
+48% |
907,580.00
+78% |
573,119.00
-37% |
879,776.00
+54% |
595,078.00
-32% |
18,320.00
-97% |
||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 0.00 | 15,806.00 | 443,517.00 | 98,893.00 | 106,642.00 | 267,129.00 | 173,203.00 | 267,140.00 | 313,274.00 | 319,769.00 | ||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
76.00
+0% |
0.00
+0% |
170,609.00
+0% |
-437,201.00
-356% |
245,557.00
-156% |
402,116.00
+64% |
640,451.00
+59% |
399,916.00
-38% |
612,636.00
+53% |
281,804.00
-54% |
-301,449.00
-207% |
||||||||
| Gross Profit Ratio | (1.00%) | (0.00%) | (0.92%) | (-69.22%) | (0.71%) | (0.79%) | (0.71%) | (0.70%) | (0.70%) | (0.47%) | (-16.45%) | ||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 0.00 | 173,684.00 | 440,876.00 | 1,504,504.00 | 1,424,718.00 | 1,444,154.00 | 1,676,417.00 | 1,898,669.00 | 1,978,888.00 | 1,070,411.00 | ||||||||
| General and Administrative | 0.00 | 109,516.00 | 260,502.00 | 391,480.00 | 739,953.00 | 348,654.00 | 384,384.00 | 374,571.00 | 513,688.00 | 477,731.00 | 1,419,756.00 | ||||||||
| Selling, General & Admin... | 0.00 | 109,516.00 | 319,443.00 | 277,234.00 | 739,953.00 | 348,654.00 | 384,384.00 | 374,571.00 | 513,688.00 | 477,731.00 | 1,690,603.00 | ||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 58,941.00 | -114,246.00 | 293,071.00 | 314,137.00 | 306,523.00 | 298,058.00 | 423,951.00 | 306,854.00 | 270,847.00 | ||||||||
| Depreciation and Amortiz... | 957.00 | 10,119.00 | 15,806.00 | 39,745.00 | 41,999.00 | 45,556.00 | 58,439.00 | 54,222.00 | 43,515.00 | 45,296.00 | 38,381.00 | ||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -582,819.00 | 926,803.00 | 1,239,938.00 | 987,475.00 | 1,440,954.00 | 250.00 | 0.00 | ||||||||
| Total Operating Expenses | 137,545.00 | 178,702.00 | 493,127.00 | 718,110.00 | 2,724,754.00 | 2,700,175.00 | 3,068,476.00 | 3,038,463.00 | 3,853,311.00 | 3,777,072.00 | 2,761,014.00 | ||||||||
| Cost and Exponses | 137,545.00 | 178,702.00 | 508,932.00 | 1,161,627.00 | 3,307,573.00 | 2,700,175.00 | 3,068,476.00 | 3,038,463.00 | 3,853,311.00 | 3,777,072.00 | 3,080,783.00 | ||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-137,469.00
+0% |
-178,702.00
+30% |
-508,930.00
+185% |
-1,155,310.00
+127% |
-3,300,789.00
+186% |
-2,191,417.00
-34% |
-2,160,896.00
-1% |
-2,465,344.00
+14% |
-2,973,535.00
+21% |
-3,181,994.00
+7% |
-3,062,463.00
-4% |
||||||||
| Operating Income Ratio | (-1,808.80%) | (0.00%) | (-2.73%) | (-182.92%) | (-9.58%) | (-4.31%) | (-2.38%) | (-4.30%) | (-3.38%) | (-5.35%) | (-167.17%) | ||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 1,032.00 | 48.00 | 409.00 | 130,073.00 | 135,847.00 | 64,480.00 | 38,114.00 | 52,864.00 | 85,962.00 | 87,045.00 | ||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,231.00 | 337.00 | 52,864.00 | 0.00 | 0.00 | ||||||||
| Total Other Income/Exp... | -137,545.00 | -68,154.00 | -233,713.00 | 408.00 | 167,069.00 | 353,651.00 | 666,471.00 | 201,675.00 | -11,181.00 | 486,762.00 | 49,097.00 | ||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -136,512.00 | -168,583.00 | -493,078.00 | -1,115,157.00 | -3,128,712.00 | -2,145,861.00 | -2,051,348.00 | -2,392,139.00 | -2,923,542.00 | -3,136,448.00 | -2,974,988.00 | ||||||||
| EBITDA ratio | (-1,796.21%) | (0.00%) | (-2.65%) | (-176.63%) | (-6.79%) | (-4.22%) | (-2.32%) | (-4.21%) | (-3.33%) | (-5.27%) | (-162.39%) | ||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -137,469.00 | -177,670.00 | -508,885.00 | -1,154,902.00 | -2,833,050.00 | -2,055,570.00 | -1,933,099.00 | -2,396,264.00 | -2,914,193.00 | -3,095,782.00 | -3,013,366.00 | ||||||||
| Income Before Tax Ratio | (-1,808.80%) | (0.00%) | (-2.73%) | (-182.85%) | (-8.22%) | (-4.04%) | (-2.13%) | (-4.18%) | (-3.31%) | (-5.20%) | (-164.49%) | ||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 50,163.00 | 79,409.00 | -186,367.00 | -100,000.00 | -467,739.00 | -135,847.00 | -63,248.00 | -38,114.00 | -112,206.00 | -85,962.00 | -604,187.00 | ||||||||
| Net Income | |||||||||||||||||||
| Net Income | -87,306.00
+0% |
-98,261.00
+13% |
-322,518.00
+228% |
-1,054,902.00
+227% |
-2,833,050.00
+169% |
-1,919,723.00
-32% |
-1,869,851.00
-3% |
-2,358,150.00
+26% |
-2,801,987.00
+19% |
-3,095,782.00
+10% |
-2,409,179.00
-22% |
||||||||
| Net Income Ratio | (-1,148.76%) | (0.00%) | (-1.73%) | (-167.02%) | (-8.22%) | (-3.77%) | (-2.06%) | (-4.11%) | (-3.18%) | (-5.20%) | (-131.51%) | ||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | ||||||||
| Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | ||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 72,876,460.00 | 93,939,770.00 | 126,224,471.00 | 126,224,471.00 | 117,558,819.00 | 117,749,630.00 | 119,372,094.00 | 137,232,931.00 | 153,337,656.00 | 167,768,283.00 | 185,321,461.00 | ||||||||
| Diluted Share Outstanding | 72,857,101.00 | 93,937,101.00 | 126,224,471.00 | 126,224,471.00 | 117,638,526.00 | 117,749,630.00 | 119,372,094.00 | 137,232,931.00 | 153,337,656.00 | 167,768,283.00 | 185,817,655.00 | ||||||||